Novartis Investigative Site

Roswell, Georgia 30076

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerosis, Glaucoma, Neoplasms, Breast, Ocular Hypertension

Studies at this site

• ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib — Stopped early
• Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular Hypertension — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed